(R)-Ostarine
CAS: 1132656-73-5
Rif. 3D-FO26598
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione | ||
| 50mg | Fuori produzione | ||
| 100mg | Fuori produzione | ||
| 250mg | Fuori produzione |
Informazioni sul prodotto
- (2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide(R)-N-(4-Cyano-3-(trifluoromethyl)phenyl )-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
Ostarine is a drug that has been shown to have therapeutic effects in prostate cancer cells. It can be used to target androgen receptor-positive prostate cancer cells, which are found in about 70% of prostate cancers. Ostarine binds to the androgen receptor and inhibits its function. This drug also has an anti-inflammatory effect on prostate cancer cells, which may be due to its ability to inhibit matrix metalloproteinase activity. Ostarine may also be used as a treatment for other types of cancers, including breast cancer, because it inhibits the growth of tumor cells by blocking the production of peptide hormones such as insulin-like growth factor 1 (IGF-1). Studies have shown that ostarine is effective against tumor cells that produce IGF-1 when treated with ostarine.
